Microchip Technology Inc. vs Philip Morris International Inc. — how do they compare? Microchip Technology Inc. trades at $76.84 (market cap $42.37B), while Philip Morris International Inc. trades at $199.45 (market cap $300.33B). The key difference: Philip Morris International Inc. is far larger — about 7.1× Microchip Technology Inc.'s market cap, and Philip Morris International Inc. pays the higher dividend (3.32%). Which is the better fit depends on your goals — on Pluang, investors hold Microchip Technology Inc. for 62 Days and Philip Morris International Inc. for 85 Days on average.
| MCHP | PM | |
|---|---|---|
Market Cap | $42.37B | $300.33B |
Volume | 8,887,625 | 3,935,700 |
Sector | Technology | Consumer Staples |
52-Week High | $102.97 | $200.50 |
52-Week Low | $49.02 | $144.33 |
Typical Hold Time | 62 Days | 85 Days |
Enterprise Value | $47.49B | $343.44B |
Dividend Yield | 2.33% | 3.32% |
Signals from Pluang's Aura AI — not financial advice
MCHP trades at $75.52, down 7.06% over 24 hours amid a bearish technical signal. The company reported a net loss of -$500K for 2025, though it has beaten EPS estimates for the last three quarters. Analyst consensus is strongly bullish with a $110.50 price target, and recent news highlights expansion in Ethernet and 48V power portfolios, plus the completed acquisition of Hailo to bolster edge AI capabilities.
The outlook is mixed: strong analyst support and strategic acquisitions in growth areas like AI and data centers present upside, but high valuation ratios, significant debt, and recent profitability challenges pose risks. The stock's near-term performance will hinge on Q3 2026 earnings and execution in high-demand semiconductor segments.
Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.
Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →